Project description:We report the application of H3K36me3 ChIP sequencing in SETD2 genotyped samples Examination of H3K36me3 in SETD2 wild-type, mutant renal cell carcinoma and SETD2 isogenic cell lines

2015-06-19 | E-GEOD-66884 | biostudies-arrayexpress

RNA-seq upon PAX8 knockdown in Renal Cell Carcinoma cell lines

Project description:RNA-seq upon PAX8 knockdown in Renal Cell Carcinoma cell lines

| PRJEB31824 | ENA

Effect of everolimus on clear cell renal cell carcinoma (ccRCC) cell lines - parental and stem cells

Project description:The aim of this study was to compare effect of everolimus on growth of different renal cell carcinoma (RCC) populations and develop design for experiments to measure the early response of everolimus in clear cell RCC (ccRCC) cell lines including renal cancer stem cells. Gene expression profiling using microarray was performed to determine the early response to everolimus after 3 days of treatment with optimizied concentration of drug in two ccRCC cell lines 1) parental clear cell renal cell carcinoma ccRCC-PCSC (HKPCSC -human parental kidney cancer stem cells) and 2) ccRCC-CSC - clear cell renal cell carcinoma -cancer stem cells (HKCSC - human kidney cancer stem cells).

2018-05-31 | GSE106819 | GEO

Lineage factor functions in renal carcinoma - ATAC-seq

Project description:Lineage factor functions in renal carcinoma - ATAC-seq

| PRJNA686367 | ENA

RNA-seq upon PAX8 knockdown in Renal Cell Carcinoma cell lines

Project description:In this experiment we examined the genes regulated by PAX8 knockdown in four renal cell carcinoma models. Four different cell lines bearing a validated doxycycline (DOX) inducible shRNA against PAX8 were treated with DOX for 96 hours and their gene expression profile analyzed by RNA-seq.

2019-06-28 | E-MTAB-7808 | biostudies-arrayexpress

Renal cell carcinoma: a proteomic approach

Project description:The proteome of clinical tissue samples diagnosed with clear cell renal cell carcinoma (ccRCC) and papillary renal cell carcinoma (pRCC) were evaluated analyzed along with the dataset identifier PXD022018 to establish a potential discriminative biomarker panel of proteins for these tumors subtypes.

2021-12-15 | PXD023296 | Pride

ChIP-seq for PAX8 and histone modifications in Renal Cell Carcinoma cell lines.

Project description:ChIP-seq for PAX8 and histone modifications in Renal Cell Carcinoma cell lines.

| PRJEB31828 | ENA